Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 170 participants.
Also called NCT01600235
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 170 participants
- Sponsor
- Registry
-
NCT01600235
-
- Other papers using this trial's data
- Therapeutic-induced hypertension in patients with noncardioembolic acute stroke
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01600235. Randomized; no masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION)
- Condition
- Stroke, Acute
- Condition
- Progressing Stroke
- Intervention (Drug)
- Phenylephrine
- Lead sponsor
- Samsung Medical Center
- Collaborator
- Inje University
- Collaborator
- Gyeongsang National University Hospital
- Collaborator
- Seoul National University Bundang Hospital
- Collaborator
- Keimyung University Dongsan Medical Center
- Collaborator
- Yeungnam University Hospital
Record details
- Record id
cardio:ct-nct01600235- Content hash
bef6226d740f78574d21a6cc1b919bd1ed3fe94a858768b81da1713660890ae8